{
  "AuthorID": "trainee",
  "AuthorURL": "https://community.macmillan.org.ukhttps://community.macmillan.org.uk/members/trainee",
  "Posts": [{
    "AuthorID": "trainee",
    "AuthorURL": "https://community.macmillan.org.ukhttps://community.macmillan.org.uk/members/trainee",
    "Content": "ER+/PR+: About 65% of estrogen-receptor-positive breast cancers are also progesterone-receptor-positive. This means that the cells have receptors for both hormones, which could be supporting the growth of the breast cancer. Regarding the presence of these receptors \"supporting the growth of the breast cancer\". ER-positive breast cancers have the most favorable outlook of all molecular sub types. Any positive test result \u2014 whether just for estrogen receptors, just for progesterone receptors, or both \u2014 means that the breast cancer is considered \u201chormone-receptor-positive.\u201d Hormonal therapy may help to slow or stop the growth of hormone-receptor-positive breast cancers by lowering your body\u2019s estrogen levels or blocking the effects of estrogen. These medications also may reduce the risk that the cancer will come back (recur). www.breastcancer.org/.../read_results",
    "MessageIndex": 6,
    "PostDate": "01/03/2018",
    "ThreadURL": "https://community.macmillan.org.uk/cancer_types/breast-cancer/f/breast-cancer-forum/71955/er8-pr8",
    "Title": "ER8. PR8"
  }]
}